Loading…
Valion Bio, Inc. is projected to decline to $0.2578 by 2027, a -18% move from its current price of $0.316. VBIO is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $0.2949 | $0.316 | $0.3387 | 0.00% |
| Aug 6 | $0.2866 | $0.316 | $0.3485 | +0.01% |
| Aug 7 | $0.2803 | $0.316 | $0.3563 | +0.01% |
| Aug 8 | $0.2752 | $0.316 | $0.363 | +0.02% |
| Aug 9 | $0.2707 | $0.3161 | $0.369 | +0.02% |
| Aug 10 | $0.2668 | $0.3161 | $0.3745 | +0.02% |
| Aug 11 | $0.2632 | $0.3161 | $0.3796 | +0.03% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.2632 | $0.3161 | $0.3796 | +0.03% |
| Week 2 | $0.244 | $0.3162 | $0.4096 | +0.05% |
| Week 3 | $0.2303 | $0.3163 | $0.4343 | +0.08% |
| Week 4 | $0.2193 | $0.3163 | $0.4563 | +0.11% |
| Week 5 | $0.2101 | $0.3164 | $0.4766 | +0.13% |
| Week 6 | $0.2021 | $0.3165 | $0.4957 | +0.16% |
| Week 7 | $0.195 | $0.3166 | $0.514 | +0.19% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Valion Bio, Inc. operates as a late-stage biopharmaceutical company in the healthcare sector. Its lead drug candidate is Entolimod, a TLR5 agonist that is in late-stage development to treat acute radiation syndrome.
The company's pipeline also comprises Entolimod to treat Neutropenia and lymphocyte exhaustion; and Entolasta, an immunologically optimized variant of Entolimod for chronic applications, such as immunosenescence. In addition, it offers CDMO services.
The company was formerly known as Tivic Health Systems, Inc. and changed its name to Valion Bio, Inc. in April 2026. The company was incorporated in 2016 and is based in San Antonio, Texas.
Valion Bio, Inc. (VBIO) is currently trading at $0.31 and has a market cap of $1.29M. Its rank is 5481.
Forecast figures place the 2026 average near the current price, with 2026 min $0.278 and max $0.4467. The horizon includes 2030 avg $0.3775 and max $0.6536; 2040 avg $0.4557 and max $0.9993; and 2050 avg $1.11 with a max of $2.55.
A major floor 71.7% below — a decisive break under it would weaken the trend.
The nearest floor, 12.0% below — buyers have tended to step in here.
The nearest ceiling, 82.6% above — a clean break opens room to run.
A major ceiling 343.0% above — clearing it would confirm fresh momentum.
Key VBIO support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of VBIO market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.2878 | Buy | $0.2963 | Buy |
| MA 10 | $0.2979 | Buy | $0.3207 | Sell |
| MA 20 | $0.3961 | Sell | $0.3819 | Sell |
| MA 50 | $0.5563 | Sell | $0.5416 | Sell |
| MA 100 | $0.7812 | Sell | $0.7764 | Sell |
| MA 200 | $1.22 | Sell | $1.92 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 32.36 | Neutral |
| Stoch RSI (14) | 49.46 | Neutral |
| CCI (20) | -58.45 | Neutral |
| Williams %R (14) | -85.90 | Info |
| MACD (12,26,9) | -0.00 | Sell |
| ROC (12) | -31.26 | Sell |
| Bollinger %B (20,2) | 0.29 | Neutral |
| Stochastic %K (14) | 14.10 | Buy |
| TRIX (15) | -2.23 | Sell |
| Awesome (5,34) | -0.17 | Sell |
| Ultimate (7,14,28) | 50.36 | Neutral |
| Momentum (10) | -0.19 | Sell |
| Aroon Osc (25) | -96.00 | Sell |
| Hull MA (9) | 0.28 | Buy |
| ADX (14) | 37.83 | Sell |
| ATR (14) | 0.02 | Info |
The 30-day technical picture is bearish. RSI14 is 30, and the moving averages show SMA50 at $0.5563 and SMA200 at $1.22. Key levels include a support at $0.278 and a resistance at $0.577. The 30-day range spans from $0.1964 to $0.4892, and annualized volatility is 100%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.278 | $0.316 | $0.4559 | 0% | Neutral | |
| $0.1878 | $0.2578 | $0.3823 | -18% | Bearish | |
| $0.1904 | $0.2779 | $0.4398 | -12% | Neutral | |
| $0.202 | $0.3107 | $0.5165 | -2% | Neutral | |
| $0.2382 | $0.3842 | $0.6652 | +22% | Bullish | |
| $0.2737 | $0.4614 | $0.8273 | +46% | Bullish | |
| $0.2136 | $0.3757 | $0.6946 | +19% | Neutral | |
| $0.1886 | $0.3454 | $0.6566 | +9% | Neutral | |
| $0.203 | $0.3868 | $0.7539 | +22% | Bullish | |
| $0.1674 | $0.3317 | $0.6615 | +5% | Neutral | |
| $0.2088 | $0.464 | $1.02 | +47% | Bullish | |
| $0.51 | $1.13 | $2.61 | +259% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.278 | $0.316 | $0.3922 | +0.00% |
| September 2026 | $0.2496 | $0.3034 | $0.3847 | -3.99% |
| October 2026 | $0.2573 | $0.3171 | $0.4104 | +4.52% |
| November 2026 | $0.2771 | $0.3455 | $0.4543 | +8.95% |
| December 2026 | $0.2713 | $0.3417 | $0.4559 | -1.08% |
Click any year to see its month-by-month VBIO forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Valion Bio, Inc.'s 2026 outlook centres on $0.316, within a $0.278 to $0.4559 range. That marks a 0% change versus current levels. A consolidation phase looks the most probable path here.
By 2027, VBIO could reach as high as $0.3823, with a base case around $0.2578 and support toward $0.1878 — roughly -18% from $0.316. A cyclical pullback looks likely — prices rarely move in a straight line.
Expect VBIO to range from $0.1904 to $0.4398 through 2028. The $0.2779 average target implies a -12% move from current prices. That is up +8% on the projected 2027 average. A consolidation phase looks the most probable path here.
The VBIO price prediction for 2029 points to an average of $0.3107 (low $0.202, high $0.5165) — a potential decline of -2% on today's $0.316. Price action looks broadly range-bound.
In 2030, VBIO is projected to trade between $0.2382 and $0.6652, averaging $0.3842 — a potential gain of +22% from today's $0.316. That is up +24% on the projected 2029 average. Buyers look set to stay in control over this stretch.
Valion Bio, Inc.'s 2031 outlook centres on $0.4614, within a $0.2737 to $0.8273 range. That is up +20% on the projected 2030 average. That marks a +46% change versus current levels. Momentum favours further upside here.
By 2032, VBIO could reach as high as $0.6946, with a base case around $0.3757 and support toward $0.2136 — roughly +19% from $0.316. A consolidation phase looks the most probable path here.
Expect VBIO to range from $0.1886 to $0.6566 through 2033. The $0.3454 average target implies a +9% move from current prices. That is -8% versus the projected 2032 average. Price action looks broadly range-bound.
The VBIO price prediction for 2034 points to an average of $0.3868 (low $0.203, high $0.7539) — a potential gain of +22% on today's $0.316. Buyers look set to stay in control over this stretch.
In 2035, VBIO is projected to trade between $0.1674 and $0.6615, averaging $0.3317 — a potential gain of +5% from today's $0.316. That is -14% versus the projected 2034 average. Price action looks broadly range-bound.
Valion Bio, Inc.'s 2040 outlook centres on $0.464, within a $0.2088 to $1.02 range. That is up +40% on the projected 2035 average. That marks a +47% change versus current levels. Buyers look set to stay in control over this stretch.
By 2050, VBIO could reach as high as $2.61, with a base case around $1.13 and support toward $0.51 — roughly +259% from $0.316. Momentum favours further upside here.
Investing $1,000 in VBIO today (≈ 3,164.556962 VBIO) could be worth
$3,586.27
+$2,586.27 (+259%) by 2050 · US Dollar
Based on the average projected VBIO price of $1.13 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in VBIOwould be worth at today's price.
$1,000 invested in VBIO on Jul 31, 2025 (≈ 289.855068 VBIO) would be worth
$91.59
-$908.41 (-90.8%) today · 0.09× · US Dollar
Based on a VBIO entry price of $3.45 vs. today's $0.316.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.297 | $1,063.97 | +6.4% |
| 1 month ago | $0.519 | $608.86 | -39.1% |
| 3 months ago | $0.92 | $343.48 | -65.7% |
| 6 months ago | $1.1 | $287.27 | -71.3% |
| 1 year ago | $3.45 | $91.59 | -90.8% |
| All time (4.7y) ago | $8,823 | $0.04 | -100.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our VBIO forecast.
Our base-case forecast reaches $0.63 around 2050.
Implied market cap at $0.63: $2.62M
2026 forecast shows min $0.278, avg $0.31, max $0.4467 with ROI 0 and sentiment NEUTRAL.
2027 forecast shows min $0.1842, avg $0.2529, max $0.3751 with ROI -18.4 and sentiment BEARISH.
2028 forecast shows min $0.1869, avg $0.2728, max $0.4318 with ROI -12 and sentiment NEUTRAL.
2029 forecast shows min $0.1981, avg $0.3047, max $0.5066 with ROI -1.7 and sentiment NEUTRAL.
2030 forecast shows min $0.234, avg $0.3775, max $0.6536 with ROI 21.8 and sentiment BULLISH. 2031 forecast shows min $0.2686, avg $0.4529, max $0.812 with ROI 46.1 and sentiment BULLISH.
2032 forecast shows min $0.209, avg $0.3677, max $0.6799 with ROI 18.6 and sentiment NEUTRAL. 2033 forecast shows min $0.1852, avg $0.3393, max $0.645 with ROI 9.5 and sentiment NEUTRAL. 2034 forecast shows min $0.1995, avg $0.3801, max $0.741 with ROI 22.6 and sentiment BULLISH.
2035 forecast shows min $0.1637, avg $0.3242, max $0.6468 with ROI 4.6 and sentiment NEUTRAL.
2040 forecast shows min $0.205, avg $0.4557, max $0.9993 with ROI 47 and sentiment BULLISH. 2050 forecast shows min $0.4998, avg $1.11, max $2.55 with ROI 258.3 and sentiment BULLISH.
These year-by-year figures illustrate a path of mixed sentiment in the near term transitioning to bullish outlooks in 2030 and beyond, with notable upside potential by 2050.
Tap a question to reveal the answer.
2030: min $0.234, avg $0.3775, max $0.6536; ROI 21.8; sentiment BULLISH.
Forecasts show a mix of neutral, bearish, and bullish years. The outlook includes bullish years in 2030, 2031, 2040 and 2050 with positive ROIs in those years, but earlier years include neutral or bearish signals. These are estimates, not guarantees.
Yes, the 2050 forecast lists a max of $2.55 with ROI 258.3, indicating potential upside under the forecast, but it is not guaranteed.
Current price is $0.31 and market cap is $1.29M.
2026: min $0.278, avg $0.31, max $0.4467; ROI 0; sentiment NEUTRAL.
Valion Bio, Inc. Community Discussion
0Share your Valion Bio, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.